Strategies for Delivering Anti-HIV Therapy in South Africa

NCT00080522 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

813

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BEHAVIORAL: Monitoring by HIV-trained primary care nurses
BEHAVIORAL: Community-based directly observed therapy (DOT)
DRUG: stavudine
DRUG: lamivudine
DRUG: efavirenz
DRUG: zidovudine
DRUG: didanosine
DRUG: lopinavir/ritonavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)